Weekly Insulin Injection Debuts in India, Offering New Option for Diabetes Care
India has introduced the world’s first once-weekly insulin injection, marking a significant advancement in diabetes management. Danish pharmaceutical company Novo…
Novo Nordisk
Read More
Novo Nordisk GBS, MAHE Deepen Partnership to Build India’s Pharmacometrics Talent and Research Ecosystem
Novo Nordisk Global Business Services (GBS) has strengthened its partnership with the Manipal Academy of Higher Education (MAHE) to accelerate…
Temasek-Backed Manipal Health files for IPO Amid Healthcare Demand Surge
Manipal Health Enterprises has announced plans to raise ₹8,000 crore (about $852 million) through a fresh share issuance as part…
Dr Reddy’s Launches Low-Cost Semaglutide Generic ‘Obeda’ in India’s Booming GLP-1 Market
Dr. Reddy’s Laboratories has entered the fast-growing GLP-1 therapy segment with the launch of its semaglutide generic, Obeda, for Type…
Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Dr Reddy’s Plans Up to 60% Cheaper Generic Version of Wegovy as Patent Nears Expiry
India’s Dr Reddy’s Laboratories is preparing to introduce a significantly lower-priced generic version of blockbuster weight-loss drug Wegovy, currently sold…
Novo Nordisk Reduces Wegovy Prices in China Amid Rising Competition
Novo Nordisk has announced a reduction in the price of its blockbuster weight-loss drug Wegovy in China, as the Danish…
Emcure Pharma Launches Semaglutide-Based Weight Loss Drug Poviztra in India
Emcure Pharmaceuticals has announced the nationwide commercial rollout of Poviztra, a semaglutide-based injection indicated for weight management. With this launch,…
Novo Nordisk Rolls out Ozempic in India at ₹2,200 per Week Amid Patent Disputes
Novo Nordisk, the Denmark-based pharmaceutical major, has formally introduced its widely used diabetes and weight-management drug Ozempic in the Indian…
Novo Nordisk to Introduce Ozempic in India This Month
Danish pharmaceutical giant Novo Nordisk (NOVOb.CO) is preparing to roll out its diabetes medication Ozempic in India within the next…
- 1
- 2